U

University Hospital Würzburg | Internal Medicine II, Haematology and Oncology Department

Research site

(Unclaimed)

Location

Medical Klinik II, Zentrum International Medicine Building A4, +1, 426, Würzburg, Bavaria, Germany

Site insights

Top conditions

Top treatments

Cabozantinib

VItamin C

Prednisone

APL-2

Teclistamab

Trametinib

Chemotherapy

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 32 total trials

A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)

This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX110 in subjects with relapsed or refractory B-cell malig...

Active, not recruiting

Adult B Cell ALL

B-cell Lymphoma

Biological: CTX110

Optimization of Sepsis Therapy Based on Patient-specific Digital Precision Diagnostics (DigiSep)

Sepsis is triggered by an infection and represents one of the greatest challenges of modern intensive care medicine. With regard to a targeted antimi...

Enrolling

Septic Shock

Sepsis

Diagnostic Test: Next Generation Sequencing (NGS)

Diagnostic Test: Standard diagnostics

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: the STEMI-DTU Trial (DTU-STEMI)

The purpose of this research study is to evaluate whether using the the IMPELLA® CP System temporary circulatory assist device for 30 minutes prior t...

Active, not recruiting

ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

Device: Impella CP® placement prior to reperfusion with Primary PCI